Zhi Qi

Zhi Qi


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Experimental Cell Research
Verified
Journal Article
Open access
HCHe Chang
He Chang
FZFayun Zhao
Fayun Zhao
XXXinwen Xie
Xinwen Xie
YLYanchun Liao
Yanchun Liao
YSYing Song
Ying Song
ZQZhi Qi
Zhi Qi
Family members of peroxisome proliferator-activated receptors (PPARs), such as PPARγ, have been shown to be effective in regulating T helper 17 (Th17) cell differentiation. However, whether PPARα, another important family member of PPARs, contributes to Th17 cell differentiation remains controversial. In the present study, we show that PPARα may be a negative regulator of Th17 cell differentiation. In CD4+ T cells from PPARα knockout mice, PPARα deficiency enhances IL-17 and IL-6 levels and promotes Th17 cell differentiation. In contrast, in CD4+ T cells from wild type mice, PPARα activation suppresses Th17 cell differentiation. Furthermore, IL-6 neutralizing antibody dose-dependently reduces the activity of STAT3 and down-regulates the protein expression of RORγt in CD4+ T cells from PPARα knockout mice but has no effect on that of wild type mice. On the other hand, in isolated CD4+ T cells from experimental autoimmune myocarditis (EAM) rats, PPARα agonist Fenofibrate decreased the expression of IL-17 and RORγt, increased the expression of Foxp3, while PPARα antagonist MK886 reversed these effects. Importantly, in vivo activation of PPARα ameliorates EAM by suppressing Th17 cell differentiation through reducing the expression of RORγt and phosphorylated STAT3 that are upregulated in EAM hearts. These results imply that PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt signaling pathway and suggest that PPARα may become a molecular target for treating autoimmune myocarditis.

21 April 2023 in Journal of Molecular Biology
Verified
Journal Article
Closed access
JLJinzhao Li
Jinzhao Li
XHXiang He
Xiang He
SGShuang Gao
Shuang Gao
YLYuchao Liang
Yuchao Liang
ZQZhi Qi
Zhi Qi
YXYongqiang Xing
Yongqiang Xing

1 July 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
HLHua-Juan Li
Hua-Juan Li
YZYu-Jiao Zhang
Yu-Jiao Zhang
LZLi Zhou
Li Zhou
FHFeng Han
Feng Han
MWMing-Yan Wang
Ming-Yan Wang
ZQZhi Qi
Zhi Qi

17 April 2018 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
CZChunlian Zhong
Chunlian Zhong
HCHe Chang
He Chang
YWYang Wu
Yang Wu
LZLi Zhou
Li Zhou
YWYan Wang
Yan Wang
JZJun Zou
Jun Zou
Prolongation of QRS duration in electrocardiogram is one of the risk factors for morbidity and mortality in many kinds of cardiac diseases. However, its molecular mechanism is unknown. In this study, utilizing experimental autoimmune myocarditis (EAM) as a disease model, we show that the prolongation of QRS duration is accompanied by elevated phosphorylation of connexin 43 (Cx43) at Ser368 (pS368Cx43). In cultured cells, inflammatory cytokine IL‐1β activates p38 MAPK to up‐regulate pS368Cx43 and impairs cell‐to‐cell communication. In isolated hearts of normal rats, perfusion of IL‐1β not only increases pS368Cx43 but also impairs cell‐to‐cell communication and prolongs QRS duration. Furthermore, blockade of p38 MAPK down‐regulates pS368Cx43, improves cell‐to‐cell communication and reduces QRS duration in EAM. These findings suggest that up‐regulation of pS368Cx43 by IL‐1β via p38 MAPK contributes to the prolongation of QRS duration and could be a therapeutic target for myocarditis‐induced prolongation of QRS duration.

1 August 2014 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
JZJun Zou
Jun Zou
XYXiao-Yang Yue
Xiao-Yang Yue
SZSheng-Chao Zheng
Sheng-Chao Zheng
GZGuangwei Zhang
Guangwei Zhang
HCHe Chang
He Chang
ZQZhi Qi
Zhi Qi

10 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
CZChunlian Zhong
Chunlian Zhong
YWYang Wu
Yang Wu
HCHe Chang
He Chang
CLChunxiao Liu
Chunxiao Liu
LZLi Zhou
Li Zhou
ZQZhi Qi
Zhi Qi
Effect of PKC inhibitor on experimental autoimmune myocarditis in Lewis rats Effect of PKC inhibitor on experimental autoimmune myocarditis in Lewis rats